Somatic mutational profiling identifies aggressive and indolent disease phenotypes in well-differentiated pancreatic neuroendocrine tumors.

In patients with metastatic tumors, the presence of a mutation in ATRX or DAXX had the longest overall survival, although these differences did not reach statistical significance ( Figure 5H ).

also in 111,027 other papers